MENU
CANF
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Can-Fite BioPharma (CANF) Ownership - Who owns Can-Fite BioPharma?
Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
26 Ben Gurion Street
Phone
+972 39241114
Employees
5
Web
http://www.canfite.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
13.48M
P/E Ratio
N/A
Total Cash
6.46M
Projected Growth
N/A
Total Debt
90K
Revenue
560K
Risk (Beta)
1.49
Dividend Yield
N/A
Total Cash/Share
0.41
Total Debt/Equity
N/A
Revenue/Share
0.06 USD as % of share price
Fundamentals
CANF
Capitalization
13.5M
P/E Ratio
N/A
Risk (Beta)
1.49
Dividend Yield
N/A
Total Cash
6.46M
Total Cash/Share
0.41
Total Debt
90K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.06%
Revenue
560K
ROE
N/A
Book Value
4.18M
P/B Ratio
2.37
Cash Flow
N/A
Earnings
0
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
3.60
Current Revenue Per Employee
31000.00
Dividends Per Share - Security
N/A
EBITDA
-8.91M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-129.00
Shares Held By Institutions
130K
Shares Outstanding - Current
15.8M
Total Liabilities
3.54M
Total Volume MTD
N/A
Value
1
Gain YTD
-61.292
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
a developer of biopharmaceuticals for treatment of autoimmune diseases and cancers
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
26 Ben Gurion Street
Phone
+972 39241114
Employees
5
Web
http://www.canfite.com